Home Stock

Stock Research: Formosa Laboratories

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Formosa Laboratories

TAI:4746 TW0004746003
55
  • Value
    50
  • Growth
    33
  • Safety
    Safety
    54
  • Combined
    41
  • Sentiment
    80
  • 360° View
    360° View
    55
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Formosa Laboratories, Inc. develops, produces, and distributes UV-proof active ingredients and pharmaceutical chemicals. It operates in the pharmaceutical industry, specializing in UV-proof active ingredients, vitamin D derivatives, anti-inflammatory analgesics, and more. The company distributes its products to Europe, the Americas, and Asia. In the last fiscal year, the company had a market cap of $281 million, profits of $62 million, and revenue of $144 million. The number of employees is not available.

more

ANALYSIS: With an Obermatt 360° View of 55 (better than 55% compared with alternatives), overall professional sentiment and financial characteristics for the stock Formosa Laboratories are above average. The 360° View is based on consolidating four consolidated indicators, with half of the indicators below and half above average for Formosa Laboratories. The consolidated Value Rank has an attractive rank of 50, which means that the share price of Formosa Laboratories is on the lower side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 50% of alternative stocks in the same industry. The company is also safely financed with a Safety rank of 54. In addition, professional market sentiment is above average compared with other stock investment alternatives with a Sentiment Rank of 80. But the consolidated Growth Rank has a low rank of 33, which means that the company is below average in terms of growth and momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. 67 of its competitors have better growth. ...read more

more
Strongest Rank Dividend Yield
Weakest Rank Profit Growth
Country Taiwan
Industry Pharmaceuticals
Size Small
Website formosalab.com
Index
Formosa Laboratories stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 13-Mar-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
50 84 76 93
Growth
33 70 89 61
Safety
Safety
54 30 24 18
Sentiment
80 80 80 70
360° View
360° View
55 89 92 65
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
62 90 87 66
Opinions Change
50 50 6 50
Pro Holdings
n/a 84 66 94
Market Pulse
86 33 100 n/a
Sentiment
80 80 80 70
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
50 84 76 93
Growth
33 70 89 61
Safety Safety
54 30 24 18
Combined
41 75 82 59
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
56 50 43 56
Price vs. Earnings (P/E)
66 93 81 97
Price vs. Book (P/B)
77 57 51 84
Dividend Yield
1 98 91 83
Value
50 84 76 93
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
36 68 92 75
Profit Growth
93 96 8 3
Capital Growth
40 58 92 33
Stock Returns
15 12 83 95
Growth
33 70 89 61
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
40 22 21 12
Refinancing
44 53 47 51
Liquidity
76 40 30 12
Safety Safety
54 30 24 18

Similar Stocks

Discover high‑ranked alternatives to Formosa Laboratories and broaden your portfolio horizons.

Daiwa House

TYO:1925
Country: Japan
Industry: Electric Utilities
Size: XX-Large
Full Stock Analysis

Kinden

TYO:1944
Country: Japan
Industry: Construction & Engineering
Size: X-Large
Full Stock Analysis

Shionogi

TYO:4507
Country: Japan
Industry: Pharmaceuticals
Size: X-Large
Full Stock Analysis

Phison Electronics

TWO:8299
Country: Taiwan
Industry: Semiconductors
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

The stock offers good value, safe financing, and positive sentiment. However, it has below-average growth expectations. It is well-suited for conservative buy-and-hold investors who prioritize stability and low valuation over growth.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews